Similar articles

• Neoadjuvant chemotherapy in invasive bladder cancer. Trial design.

  Parmer MK. Parmer MK. Prog Clin Biol Res. 1990;353:115-8. Prog Clin Biol Res. 1990. PMID: 2217408 No abstract available.
• Endpoints of clinical trials for muscle-invasive bladder cancer.

  Tannock IF. Tannock IF. Prog Clin Biol Res. 1990;353:65-74. Prog Clin Biol Res. 1990. PMID: 2217428 Review. No abstract available.
• Neoadjuvant treatment for invasive bladder cancer: is it worthwhile?

  Hall RR. Hall RR. Acta Urol Belg. 1996 May;64(2):39-42. Acta Urol Belg. 1996. PMID: 8701809 No abstract available.
• The case for neoadjuvant chemotherapy and cystectomy for muscle invasive bladder cancer.

  deVere White RW, Katz MH, Steinberg GD. deVere White RW, et al. J Urol. 2009 May;181(5):1994-7. doi: 10.1016/j.juro.2009.02.052. Epub 2009 Mar 14. J Urol. 2009. PMID: 19286209 Review. No abstract available.
• Neoadjuvant and adjuvant chemotherapy for invasive bladder cancer.

  Smith MR, Kantoff PW. Smith MR, et al. Semin Oncol. 1995 Dec;22(6):625-32. Semin Oncol. 1995. PMID: 8539637 Review.